MedPath

Effect of nutritional supplements in the treatment of polycystic ovary syndrome

Phase 2
Recruiting
Conditions
Polycystic Ovary Syndrome (PCOS).
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20240407061432N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Woman aged 18-40 with PCOS confirmed by a gynecologist (new case)

Exclusion Criteria

Pregnant women
Menopausal women
Women who underwent oophorectomy or hysterectomy
Women using oral contraceptive pills (OCP)
Women who previously used dietary supplements
Lack of interest in study participation
Age < 18 years
Age > 40 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The ratio of changes in target gene expression. Timepoint: Gene expression measured at the beginning of the study (before the intervention) and 2 months after starting the candidate food supplement (Vit D). Method of measurement: Real- Time RT-PCR.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath